Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Schedule of Summarizes Information About Stock Options (Details)

v3.20.2
Stock-Based Compensation - Schedule of Summarizes Information About Stock Options (Details)
shares in Thousands
6 Months Ended
Jun. 30, 2020
$ / shares
shares
2014 Long Term Incentive Equity Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Stock Options Outstanding, Beginning Balance | shares 5,204
Number of Stock Options, Granted | shares 1,345
Number of Stock Option, Exercised | shares
Number of Stock Option, Forfeited | shares
Number of Stock Options Outstanding, Ending Balance | shares 6,549
Number of Stock Options Vested and exercisable stock options | shares 4,016
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 2.68
Weighted Average Exercise Price, Granted | $ / shares 2.18
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Exercise Price, Ending Balance | $ / shares 2.58
Weighted Average Exercise Price, Vested and exercisable stock options | $ / shares $ 313
Remaining Contractual Term (Years) stock options, Beginning 8 years 1 month 6 days
Remaining Contractual Term (Years) stock options, Exercised 9 years 9 months 18 days
Remaining Contractual Term (Years) stock options, Ending Balance 7 years 8 months 12 days
Remaining Contractual Term (Years), Vested and exercisable stock options 7 years 3 months 19 days
2018 Stock Plan [Member] | Lucid Diagnostics Inc [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Stock Options Outstanding, Beginning Balance | shares 995
Number of Stock Options, Granted | shares
Number of Stock Option, Exercised | shares 3
Number of Stock Option, Forfeited | shares
Number of Stock Options Outstanding, Ending Balance | shares 992
Number of Stock Options Vested and exercisable stock options | shares 574
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 0.86
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Exercised | $ / shares 1.50
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Exercise Price, Ending Balance | $ / shares 0.86
Weighted Average Exercise Price, Vested and exercisable stock options | $ / shares $ 0.83
Remaining Contractual Term (Years) stock options, Beginning 9 years
Remaining Contractual Term (Years) stock options, Ending Balance 8 years 6 months
Remaining Contractual Term (Years), Vested and exercisable stock options 8 years 4 months 24 days